Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q54536549)
Watch
English
MEK'ing the most of p53 reactivation therapy in melanoma.
scientific article
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22241441
title
MEK'ing the most of p53 reactivation therapy in melanoma.
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22241441
author
Meenhard Herlyn
series ordinal
2
object named as
Meenhard Herlyn
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
author name string
John T Lee
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22241441
language of work or name
English
0 references
publication date
1 February 2012
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22241441
published in
Journal of Investigative Dermatology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22241441
volume
132
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22241441
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22241441
page(s)
263-265
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22241441
cites work
How to make a melanoma: what do we know of the primary clonal events?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2011.362
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Current strategies to target p53 in cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2011.362
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2011.362
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Basal and treatment-induced activation of AKT mediates resistance to cell death by AZD6244 (ARRY-142886) in Braf-mutant human cutaneous melanoma cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2011.362
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when combined with docetaxel
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2011.362
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
p53 rescue through HDM2 antagonism suppresses melanoma growth and potentiates MEK inhibition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2011.362
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Selective activation of p53-mediated tumour suppression in high-grade tumours
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2011.362
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MEK-ERK signaling controls Hdm2 oncoprotein expression by regulating hdm2 mRNA export to the cytoplasm.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2011.362
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mutant BRAF melanomas--dependence and resistance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2011.362
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FJID.2011.362
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/JID.2011.362
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22241441
PubMed publication ID
22241441
1 reference
stated in
Europe PubMed Central
PubMed publication ID
22241441
retrieved
31 May 2018
reference URL
http://europepmc.org/abstract/MED/22241441
ResearchGate publication ID
221744160
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
